AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (979.3 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese

Effects of Auer rod on prognosis in patients with freshly-diagnosed non-M3 type acute myeloid leukemia

Yarui HUANGXingqin HUANGXiangtao HUANGChengxin LUOShuangnian XUJieping CHEN( )
Center of Hematology, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China
Show Author Information

Abstract

Objective

To investigate the effects of Auer rod on the prognosis of newly-diagnosed non-M3 type acute myeloid leukemia (AML).

Methods

A retrospective cohort study was performed on 154 patients initially diagnosed as non-M3 type AML in our center from January 2012 to December 2019. According to the presence or absence of Auer rod in the bone marrow blasts, the patients were divided into Auer rod positive and negative groups. Their follow-up data were obtained from medical records and through telephone conversations with the enrolled patients. Clinical data were compared between the 2 groups, including gender, age, white blood cell (WBC) count, platelet (PLT) count, hemoglobin (Hb), lactate dehydrogenase (LDH), French-American-British (FAB) classification, percentage of blast cells in bone marrow, and cytogenetic risk stratification. Kaplan-Meier survival analysis and multivariate COX regression model were used to analyze the difference in outcome of time-events between the 2 groups.

Results

As compared with the Auer rod negative group, the Auer rod positive group had higher proportion of M2 type (P<0.001) but lower proportion of M5 type (P=0.005) in FAB classification, lower percentage of bone marrow blasts (P<0.001), higher mutation frequency of WT1 gene (P=0.006), and lower mortality rate (P=0.008). The overall survival (OS) was significantly longer in the Auer rod positive group than the negative group (P=0.01). Multivariate COX regression analysis showed that Auer rod was an independent influencing factor for OS (HR=0.298, 95%CI: 0.104~0.853, P=0.024).

Conclusion

Auer rod is an independent prognostic factor of AML, and presents good prognostic value.

CLC number: R557 Document code: A

References

[1]
FORAN J M. New prognostic markers in acute myeloid leukemia: perspective from the clinic[J]. Hematol Am Soc Hematol Educ Program, 2010, 2010: 47-55. DOI: 10.1182/asheducation-2010.1.47.
[2]
KELLAWAY S, CHIN P S, BARNEH F, et al. T(8;21) acute myeloid leukemia as a paradigm for the understanding of leukemogenesis at the level of gene regulation and chromatin programming[J]. Cells, 2020, 9(12): 2681. DOI: 10.3390/cells9122681.
[3]
DÖHNER H, WEISDORF D J, BLOOMFIELD C D. Acute myeloid leukemia[J]. N Engl J Med, 2015, 373(12): 1136-1152. DOI: 10.1056/nejmra1406184.
[4]
LIU L, CHEN R, ZHANG Y, et al. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia[J]. Diagn Pathol, 2015, 10: 109. DOI: 10.1186/s13000-015-0345-6.
[5]
HUANG H, QIN T, XU Z, et al. Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia[J]. Br J Haematol, 2020, 188(5): 796-800. DOI: 10.1111/bjh.16326.
[6]
GUPTA A, REDDY G K, NALLA N, et al. Lymphoblasts with Auer rod-like inclusions in a case of paediatric B lymphoblastic leukemia[J]. Pediatr Blood Cancer, 2017, 64(7): e26392. DOI: 10.1002/pbc.26392.
[7]
KRIS M G, MERTELSMANN R, JHANWAR S, et al. Relationship of auer rods and chromosome findings to outcome in eighty-nine adults with acute nonlymphoblastic leukemia[J]. Leuk Res, 1985, 9(10): 1231-1235. DOI: 10.1016/0145-2126(85)90150-X.
[8]
MERTELSMANN R, TZVI THALER H, TO L, et al. Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia[J]. Blood, 1980, 56(5): 773-781.
[9]
RITTER J, VORMOOR J, CREUTZIG U, et al. Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83[J]. Med Pediatr Oncol, 1989, 17(3): 202-209. DOI: 10.1002/mpo.2950170307.
[10]
VARDIMAN J W, THIELE J, ARBER D A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes[J]. Blood, 2009, 114(5): 937-951. DOI: 10.1182/blood-2009-03-209262.
[11]
DÖHNER H, ESTEY E H, AMADORI S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European Leukemia Net[J]. Blood, 2010, 115(3): 453-474. DOI: 10.1182/blood-2009-07-235358.
[12]
ZHANG Z N. Criteria for diagnosis and curative effect of hematological diseases[M]. 2nd ed. Tianjin: Tianjin Science and Technology Press, 1998: 171-183.
[13]
NARAYANAN D, WEINBERG O K. How I investigate acute myeloid leukemia[J]. Int J Lab Hematol, 2020, 42(1): 3-15. DOI: 10.1111/ijlh.13135.
[14]
VAGO L, GOJO I. Immune escape and immunotherapy of acute myeloid leukemia[J]. J Clin Invest, 2020, 130(4): 1552-1564. DOI: 10.1172/jci129204.
[15]
HASSAN H T, REES J K. Auer bodies in acute myeloid leukaemia patients[J]. Pathol Res Pract, 1990, 186(2): 293-295. DOI: 10.1016/s0344-0338(11)80547-9.
[16]
BILLSTRÖM R, NILSSON P G, MITELMAN F. Characteristic patterns of chromosome abnormalities in acute myeloid leukemia with Auer rods[J]. Cancer Genet Cytogenet, 1987, 28(2): 191-199. DOI: 10.1016/0165-4608(87)90205-6.
[17]
JIANG Y H, JIAO Y, CHEN G Y, et al. Comparative analysis of clinical characteristics between Auer body positive and negative de novo primary acute myeloid leukemia patients (non-AML-M3 type)[J]. Guangdong Med J, 2020, 41(7): 702-707. DOI: 10.13820/j.cnki.gdyx.20192056.
[18]
ZITTOUN R, CADIOU M, BAYLE C, et al. Prognostic value of cytologic parameters in acute myelogenous leukemia[J]. Cancer, 1984, 53(7): 1526-1532. DOI: 10.1002/1097-0142(19840401)53:71526:aid-cncr2820530718>3.0.co;2-2.
[19]
STASS S A, LANHAM G R, BUTLER D, et al. Auer rods in mature granulocytes: a unique morphologic feature of acute myelogenous leukemia with maturation[J]. Am J Clin Pathol, 1984, 81(5): 662-665. DOI: 10.1093/ajcp/81.5.662.
[20]
JIA H F, MA R L, GAO Y, et al. Value of Auer rod in the diagnosis of acute myeloid leukemia[J]. Proceeding Clin Med, 2004, 13(12): 902-903. DOI: 10.3969/j.issn.1671-8631.2004.12.008.
[21]
YANG Y X, LIN Y P, XIONG S M. The value of Auer corpuscle in the diagnosis of ANLL: an analysis of 255 cases[J]. Shanghai J Med Lab Sci, 1998, 13(1): 40-41.
[22]
YANADA M, TERAKURA S, YOKOZAWA T, et al. Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia[J]. Leuk Lymphoma, 2004, 45(9): 1803-1808. DOI: 10.1080/10428190410001693551.
[23]
LUO S, YU K, YAN Q X, et al. Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia[J]. Leuk Lymphoma, 2014, 55(2): 349-357. DOI: 10.3109/10428194.2013.791985.
[24]
HU Z L, HUANG B J, PAN S J. Effect of WT1 gene high expression and CD34+ and auer+ on prognosis of acute myeloid leukemia[J]. J Exp Hematol, 2016, 24(6): 1670-1674. DOI: 10.7534/j.issn.1009-2137.2016.06.011.
Journal of Army Medical University
Pages 224-230
Cite this article:
HUANG Y, HUANG X, HUANG X, et al. Effects of Auer rod on prognosis in patients with freshly-diagnosed non-M3 type acute myeloid leukemia. Journal of Army Medical University, 2022, 44(3): 224-230. https://doi.org/10.16016/j.2097-0927.202106069

25

Views

1

Downloads

0

Crossref

0

Scopus

0

CSCD

Altmetrics

Received: 08 June 2021
Revised: 10 August 2021
Published: 15 February 2022
© 2022 Journal of Army Medical University
Return